CompanyNasdaqReno, NV
Conexeu Sciences Inc
Conexeu Sciences is a preclinical-stage company developing CXU, a bioregenerative extracellular matrix platform for wound care, periodontal applications, and tissue restoration.
DSep 29Latest SEC filing
Form DSep 15$252K sold
September 2026